10.67 USD
↘ 0.32 (2.91%)AT CLOSE (03:59 PM EST)
Enanta Pharmaceuticals, Inc (ENTA) trades at $11.05 per share. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics place ENTA at a fair price relative to peers.
Technical & fundamental data as of Nov 16, 2026.